Cargando…

Glucocorticoid‐induced osteoporosis in rheumatic diseases

The aim of this article is to review rheumatological diseases that are associated with glucocorticoid‐induced osteoporosis or fractures and to perform a critical analysis of the current guidelines and treatment regimens. The electronic database MEDLINE was searched using the date range of July 1986...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Rosa Maria Rodrigues, de Carvalho, Jozélio Freire, Canalis, Ernesto
Formato:	Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999719/ https://www.ncbi.nlm.nih.gov/pubmed/21243296 http://dx.doi.org/10.1590/S1807-59322010001100024

Ejemplares similares

Mechanisms of glucocorticoid induced osteoporosis
por: Canalis, E
Publicado: (2004)

Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review
por: Skare, Thelma L., et al.
Publicado: (2023)

Oral pulsed high-dose dexamethasone therapy for rheumatic diseases: An alternative safe and effective scheme
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

Sydenham’s Chorea as the First Manifestation of Rheumatic Fever in Two Boys
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2021)

Pearls in autoimmunity
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2011)

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)

Rheumatic Fever Associated with Antiphospholipid Syndrome: Systematic Review
por: da Silva, Felipe, et al.
Publicado: (2014)

Glucocorticoid-induced osteoporosis: an update
por: Compston, Juliet
Publicado: (2018)

Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
por: Freire de Carvalho, Jozélio, et al.
Publicado: (2021)

Update on Glucocorticoid Induced Osteoporosis
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Zebrafish models for glucocorticoid-induced osteoporosis
por: Lin, Wen-Ying, et al.
Publicado: (2022)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Clinical and therapeutical features of patients with systemic lupus erythematosus associated with gastroparesis: A systematic review
por: de Carvalho, Jozélio Freire
Publicado: (2022)

“Neuroimmunoendocrinology” in Children with Rheumatic Diseases: How Glucocorticoids Are the Orchestra Director
por: Maggio, Maria Cristina, et al.
Publicado: (2023)

Glucocorticoid-Induced Osteoporosis: Increased Awareness as a Management Strategy for Prevention of this Complication in Patients with Systemic Autoimmune Rheumatic Disease
por: Bankole, Adegbenga, et al.
Publicado: (2023)

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
por: Ventura, Annamaria, et al.
Publicado: (2013)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
por: Peng, Cheng-Huan, et al.
Publicado: (2021)

Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2009)

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
por: Payer, Juraj, et al.
Publicado: (2010)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice
por: Adami, Giovanni, et al.
Publicado: (2019)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Linking glucocorticoid-induced osteoporosis to osteoimmunology
por: von Gunten, Stephan, et al.
Publicado: (2020)

Still's Disease and Recurrent Complex Regional Pain Syndrome Type-I: The First Description
por: Faillace, César, et al.
Publicado: (2012)

Lidocaine in fibromyalgia: A systematic review
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2022)

Primary Antiphospholipid Syndrome with and Without Acute Myocardial Infarction/Angina: A Cross-Sectional Study
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2022)

Mesenteric Vasculitis in a Systemic Lupus Erythematosus Patient with a Low Sledai: An Uncommon Presentation
por: de Carvalho, Jozélio Freire
Publicado: (2010)

Tietze’s Syndrome
por: de Carvalho, Jozélio Freire
Publicado: (2022)

A sarcoidosis patient developing psoriatic arthritis 18 years later: First description
por: de Carvalho, Jozélio Freire
Publicado: (2023)

New-onset of juvenile systemic lupus erythematosus following COVID-19 vaccination: First case report
por: de Carvalho, Jozélio Freire
Publicado: (2023)

Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis
por: Zhou, Rui-Xin, et al.
Publicado: (2023)

Erythema induratum of Bazin associated with Addison’s disease: first description
por: Brandão, Rodrigo Antonio, et al.
Publicado: (2013)

Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
por: Aikawa, Nadia Emi, et al.
Publicado: (2011)

Heparin Increases HLA-G Levels in Primary Antiphospholipid Syndrome
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vklem0g0naet7bd6abqtuvv7n0